2020
A current review of COVID-19 for the cardiovascular specialist
Lang J, Wang X, Moura F, Siddiqi H, Morrow D, Bohula E. A current review of COVID-19 for the cardiovascular specialist. American Heart Journal 2020, 226: 29-44. PMID: 32497913, PMCID: PMC7252118, DOI: 10.1016/j.ahj.2020.04.025.Peer-Reviewed Original ResearchMeSH KeywordsAdenosine MonophosphateAlanineAntimalarialsAntiviral AgentsBetacoronavirusBiomarkersCardiovascular DiseasesChloroquineCoronavirus InfectionsCOVID-19HumansHydroxychloroquineHypoxiaPandemicsPlasmaPneumonia, ViralReceptor, Angiotensin, Type 2Risk FactorsSARS-CoV-2Takotsubo CardiomyopathyVirus InternalizationConceptsAcute cardiac injuryCardiac injuryAdverse outcomesLevels of cardiac troponinAssociated with adverse outcomesHyperinflammatory cytokine stormType 2 myocardial infarctionPre-existing cardiovascular diseaseLevel of suspicionComplications of COVID-19Stress-related cardiomyopathyIncreased blood levelsCardiovascular risk factorsNonischemic myocardial injurySevere COVID-19Cardiovascular complications of COVID-19Nonischemic causesTakotsubo syndromeNatriuretic peptideD-dimerHigher mortality riskCardiovascular complicationsDiffuse thrombosisInflammatory milieuMyocardial dysfunction
2012
Emergent cardiovascular risk factors in the very elderly
Moura F, Freitas W, Sposito A. Emergent cardiovascular risk factors in the very elderly. Expert Review Of Cardiovascular Therapy 2012, 10: 1221-1225. PMID: 23190062, DOI: 10.1586/erc.12.98.Peer-Reviewed Original ResearchAtherosclerotic disease in octogenarians: A challenge for science and clinical practice
Freitas W, Carvalho L, Moura F, Sposito A. Atherosclerotic disease in octogenarians: A challenge for science and clinical practice. Atherosclerosis 2012, 225: 281-289. PMID: 22858284, DOI: 10.1016/j.atherosclerosis.2012.06.070.Peer-Reviewed Original Research